Eli Lilly and Company General Manager of South ASEAN, Dr. Faiz Ansari speaks about the expanded scope of his role, Lilly’s pipeline, and the approach that Lilly has taken to support healthcare delivery and improve patients‘ access to treatment and to support programs in a region that is so inherently disparate in nature.
Now with Singapore, Malaysia, and Brunei under your purview, in addition to Indonesia, how has your experience been transitioning to a regional role?
"Since 1997, Lilly has established a partnership with the National University of Singapore, and the National Science and Technology Board (NSTB) to form Lilly-NUS R&D center, one of Lilly’s six R&D centers across the world."
